Literature DB >> 28771896

Dual, Site-Specific Modification of Antibodies by Using Solid-Phase Immobilized Microbial Transglutaminase.

Philipp R Spycher1, Christian A Amann1, Jöri E Wehrmüller1, David R Hurwitz1, Olivier Kreis1, Daniel Messmer2, Andreas Ritler1,3, Andreas Küchler2, Alain Blanc1, Martin Béhé1, Peter Walde2, Roger Schibli1,4.   

Abstract

Microbial transglutaminase (MTG) was stably solid-phase immobilized on glass microbeads by using a second-generation dendronized polymer. Immobilized MTG enabled the efficient generation of site-specifically conjugated proteins, including antibody fragments, as well as whole antibodies through distinct glutamines and, unprecedentedly, also through lysines with various bifunctional substrates with defined stoichiometries. With this method, we generated dual, site-specifically modified antibodies comprising a fluorescent probe and a metal chelator for radiolabeling-a strategy anticipated to design antibodies for imaging and simultaneous therapy. Furthermore, we provide evidence that immobilized MTG features higher siteselectivity than soluble MTG.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antibodies; bioconjugation; immobilization; site-specific modification; transglutaminase

Mesh:

Substances:

Year:  2017        PMID: 28771896     DOI: 10.1002/cbic.201700188

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  13 in total

Review 1.  Recent progress in enzymatic protein labelling techniques and their applications.

Authors:  Yi Zhang; Keun-Young Park; Kiall F Suazo; Mark D Distefano
Journal:  Chem Soc Rev       Date:  2018-09-27       Impact factor: 54.564

2.  ImmunoPET: Concept, Design, and Applications.

Authors:  Weijun Wei; Zachary T Rosenkrans; Jianjun Liu; Gang Huang; Quan-Yong Luo; Weibo Cai
Journal:  Chem Rev       Date:  2020-03-23       Impact factor: 60.622

Review 3.  Enzymatic Methods for the Site-Specific Radiolabeling of Targeting Proteins.

Authors:  Cristina Bolzati; Barbara Spolaore
Journal:  Molecules       Date:  2021-06-08       Impact factor: 4.411

4.  Dextramabs: A Novel Format of Antibody-Drug Conjugates Featuring a Multivalent Polysaccharide Scaffold.

Authors:  Hendrik Schneider; Lukas Deweid; Thomas Pirzer; Desislava Yanakieva; Simon Englert; Bastian Becker; Olga Avrutina; Harald Kolmar
Journal:  ChemistryOpen       Date:  2019-03-28       Impact factor: 2.911

5.  Stable Immobilization of Enzymes in a Macro- and Mesoporous Silica Monolith.

Authors:  Chengmin Hou; Nicolas Ghéczy; Daniel Messmer; Katarzyna Szymańska; Jozef Adamcik; Raffaele Mezzenga; Andrzej B Jarzębski; Peter Walde
Journal:  ACS Omega       Date:  2019-04-29

6.  Probing the limits of Q-tag bioconjugation of antibodies.

Authors:  Cristina Marculescu; Abirami Lakshminarayanan; Joseph Gault; James C Knight; Lisa K Folkes; Thomas Spink; Carol V Robinson; Katherine Vallis; Benjamin G Davis; Bart Cornelissen
Journal:  Chem Commun (Camb)       Date:  2019-09-19       Impact factor: 6.065

7.  Site-specific conjugation of native antibody.

Authors:  Amissi Sadiki; Shefali R Vaidya; Mina Abdollahi; Gunjan Bhardwaj; Michael E Dolan; Harpreet Turna; Varnika Arora; Athul Sanjeev; Timothy D Robinson; Andrea Koid; Aashka Amin; Zhaohui Sunny Zhou
Journal:  Antib Ther       Date:  2020-12-18

8.  Bivalent EGFR-Targeting DARPin-MMAE Conjugates.

Authors:  Lennard Karsten; Nils Janson; Vadim Le Joncour; Sarfaraz Alam; Benjamin Müller; Jayendrakishore Tanjore Ramanathan; Pirjo Laakkonen; Norbert Sewald; Kristian M Müller
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

9.  Bifunctional Reagents for Formylglycine Conjugation: Pitfalls and Breakthroughs.

Authors:  Nils Janson; Tobias Krüger; Lennard Karsten; Mareile Boschanski; Thomas Dierks; Kristian M Müller; Norbert Sewald
Journal:  Chembiochem       Date:  2020-09-18       Impact factor: 3.164

Review 10.  Streptomycetes as platform for biotechnological production processes of drugs.

Authors:  Simona Barbuto Ferraiuolo; Marcella Cammarota; Chiara Schiraldi; Odile Francesca Restaino
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-04       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.